Business Description
Wai Yuen Tong Medicine Holdings Ltd
ISIN : BMG9421Y2332
Compare
Compare
Traded in other countries / regions
00897.Hong Kong IPO Date
1997-10-31Description
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | 10.25 | |||||
| Interest Coverage | 0.22 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 0.85 | |||||
| Beneish M-Score | -2.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year FCF Growth Rate | -22.6 | |||||
| 3-Year Book Growth Rate | -17.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 89.8 | |||||
| 9-Day RSI | 78.42 | |||||
| 14-Day RSI | 70.23 | |||||
| 6-1 Month Momentum % | -31.64 | |||||
| 12-1 Month Momentum % | 135.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 718.21 | |||||
| Days Sales Outstanding | 37.4 | |||||
| Days Payable | 57.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 12.3 | |||||
| Dividend Payout Ratio | 30 | |||||
| Forward Dividend Yield % | 12.3 | |||||
| 5-Year Yield-on-Cost % | 12.3 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 467.38 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.24 | |||||
| Operating Margin % | 1.03 | |||||
| Net Margin % | 0.63 | |||||
| FCF Margin % | 20.12 | |||||
| ROE % | 0.3 | |||||
| ROA % | 0.14 | |||||
| ROIC % | -0.65 | |||||
| ROC (Joel Greenblatt) % | 2.85 | |||||
| ROCE % | 1.26 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.8 | |||||
| PE Ratio without NRI | 244 | |||||
| Shiller PE Ratio | 6.59 | |||||
| PS Ratio | 0.37 | |||||
| PB Ratio | 0.23 | |||||
| Price-to-Tangible-Book | 0.23 | |||||
| Price-to-Free-Cash-Flow | 1.85 | |||||
| Price-to-Operating-Cash-Flow | 1.79 | |||||
| EV-to-EBIT | 14.81 | |||||
| EV-to-EBITDA | 14.81 | |||||
| EV-to-Revenue | 0.66 | |||||
| EV-to-FCF | 3.28 | |||||
| Price-to-Projected-FCF | 0.15 | |||||
| Price-to-Median-PS-Value | 3.49 | |||||
| Price-to-Graham-Number | 1.63 | |||||
| Earnings Yield (Greenblatt) % | 6.75 | |||||
| FCF Yield % | 55.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wai Yuen Tong Medicine Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 762.398 | ||
| EPS (TTM) (HK$) | 0.005 | ||
| Beta | -0.1 | ||
| Volatility % | 125.1 | ||
| 14-Day RSI | 70.23 | ||
| 14-Day ATR (HK$) | 0.013849 | ||
| 20-Day SMA (HK$) | 0.21245 | ||
| 12-1 Month Momentum % | 135.98 | ||
| 52-Week Range (HK$) | 0.093263 - 0.435 | ||
| Shares Outstanding (Mil) | 1,125.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wai Yuen Tong Medicine Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wai Yuen Tong Medicine Holdings Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wai Yuen Tong Medicine Holdings Ltd Frequently Asked Questions
What is Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897)'s stock price today?
The current price of HKSE:00897 is HK$0.24. The 52 week high of HKSE:00897 is HK$0.44 and 52 week low is HK$0.09.
When is next earnings date of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897)?
The next earnings date of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) is .
Does Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) pay dividends? If so, how much?
The Dividend Yield %  of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) is 12.3% (As of Today), Highest Dividend Payout Ratio of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) was 30. The lowest was 0.29. And the median was 0.29. The  Forward Dividend Yield % of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) is 12.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers